China Mobile's net profit in 2025 exceeds 130 billion yuan, while CNOOC's annual profit decreases by approximately 10% year-on-year.

MaticHoleFiller · 2026-03-26T13:39:08+00:00

Cailian Press provides important Hong Kong stock announcements, involving the 2025 performance data of multiple companies, such as China Mobile and Ping An Insurance, both achieving revenue growth. Some companies like Meituan and China National Offshore Oil Corporation experienced profit declines. The report also mentions buyback activities, including companies like Pop Mart and Tencent Holdings. Overall performance varies, reflecting market dynamics and company operations.

MaticHoleFiller

2026-03-26 13:39:08

Abstract generation in progress

Cailian Press, March 26 (Editor Feng Yi) brings you important announcements from the Hong Kong stock market today:

Performance Highlights

China Mobile (00941.HK): Revenue of 1,050.187 billion yuan in 2025, up 0.9% year-over-year; profit of 137.095 billion yuan, down 0.9%.

The announcement states that 5G network customers reached 642 million, a net increase of 89.6 million, with a penetration rate of 63.9%. During the period, data center revenue grew 8.7% year-over-year, with AIDC revenue up 35.4%. Computing power service revenue grew rapidly, reaching 89.8 billion yuan, an increase of 11.1%.

Ping An Insurance (02318.HK): Revenue of 1,140.324 billion yuan in 2025, net profit of 134.778 billion yuan, up 6.45% year-over-year.

People’s Insurance Group of China (01339.HK): Total operating revenue of 669.254 billion yuan in 2025, up 7.56%; net profit of 46.207 billion yuan, up 9.62%.

China Pacific Insurance (02601.HK): Total revenue of 435.156 billion yuan in 2025, up 7.7%; net profit of 53.505 billion yuan, up 19.0%.

CNOOC (00883.HK): Revenue of 398.22 billion yuan in 2025, down 5.3% year-over-year; net profit of 122.082 billion yuan, down 11.5%.

Meituan-W (03690.HK): Revenue of 364.855 billion yuan in 2025, up 8.1%; loss of 23.354 billion yuan, adjusted net loss of 18.648 billion yuan. During the period, core local commerce segment’s operating profit declined significantly, and new business segment’s operating loss expanded to 10.1 billion yuan.

Huaneng International Power (01071.HK): Total revenue of 126.013 billion yuan in 2025, down 10.95% year-over-year; net profit of 6.07 billion yuan, up 1.4%.

Beijing Capital (00392.HK): Revenue of 87.228 billion yuan in 2025, up 3.76%; profit of 5.056 billion yuan, down 1.31%.

China Biopharmaceutical (01177.HK): Revenue of 31.834 billion yuan in 2025, up 10.25%; net profit of 2.343 billion yuan, down 33.04%. Over the past three years, 16 innovative products have been approved, including 7 Class 1 innovative drugs listed in China.

SMIC (00981.HK): Revenue of $9.327 billion in 2025, up 16.2%; net profit of $685 million, up 39%.

SinoFortune Shipping (00716.HK): Revenue of $482 million in 2025, down 17.37%; net profit of $17.411 million, down 48.99%.

Rainbow International Group (02678.HK): Revenue of 22.716 billion yuan in 2025, down 1.4%; net profit of 913 million yuan, up 63.05%. Gross margin increased from about 12.4% last year to approximately 13.8% this year.

Chow Tai Fook (00116.HK): Revenue of HKD 22.446 billion in 2025, up 6%; net profit of HKD 1.717 billion, up 113.2%, with sales rebounding.

China Overseas Property (02669.HK): Revenue of 14.96 billion yuan in 2025, up 6%; profit of 1.367 billion yuan, down 9.74%.

Sino Land (00124.HK): Revenue of HKD 8.571 billion in 2025, up 26.8%; loss of HKD 590 million, narrowed by 57.3%.

Yuexiu Services (06626.HK): Total revenue of HKD 3.902 billion in 2025, up 0.9%; net profit of HKD 274 million.

iFlytek (09678.HK): Revenue of about HKD 1.211 billion in 2025, up 29%; adjusted loss of about HKD 126.5 million, narrowed by 24.9%. Revenue from large model-related business reached HKD 610 million, increasing over 10 times year-over-year.

Company News

Yangtze Optical Fibre and Cable (06869.HK): Noted recent abnormal fluctuations in A-share trading; market share of new optical fiber products remains small.

Fuhong Hanlin (02696.HK): The first patient in China (excluding Hong Kong, Macau, Taiwan) was dosed in a Phase 1b/2 clinical trial of HLX701 combined with cetuximab and chemotherapy for advanced colorectal cancer.

Hengrui Medicine (01276.HK): HRS9531 injection approved to start clinical trials. It is a new dual agonist targeting GIPR and GLP-1R, with independent intellectual property rights, capable of regulating glucose and lipid metabolism, suppressing appetite, and enhancing insulin sensitivity, thus improving blood sugar and reducing weight.

Cstone Pharmaceuticals (02616.HK): Latest clinical progress of the self-developed PD-1/VEGF/CTLA-4 triple-specific antibody CS2009.

China Power (02380.HK): The total combined electricity sales in the first two months reached 18.592 billion kWh, with total sales of 8.132 billion kWh.

Buyback Updates

Pop Mart (09992.HK): Spent HKD 600 million to repurchase 3.94 million shares at HKD 148.4-157.8 per share.

Kuaishou-W (01024.HK): Spent HKD 298 million to buy back 6.52 million shares at HKD 45.44-46.10.

Tencent Holdings (00700.HK): Spent HKD 295 million to repurchase 590,000 shares at HKD 495.2-506.

Li Auto-W (02015.HK): Spent HKD 42.496 million to buy back 610,000 shares at HKD 68.7-70.45.

COSCO Shipping Holdings (01919.HK): Spent HKD 33.261 million to buy back 2.2 million shares at HKD 14.95-15.34.

NetEase Cloud Music (09899.HK): Spent HKD 14.995 million to repurchase 118,100 shares at HKD 125.9-129.6.

Botech Auto (02889.HK): Plans to conduct share repurchases on the market, up to 10% of the total issued H-shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.